HIV and tuberculosis trends in the United States and select Sub-Saharan Africa countries

International Journal of Environmental Research and Public Health

Volumn 8, Issue 6, 2011, Pages 2524-2532

  Mahmud, Ousman ^a   Dates, Centdrika ^a   Akil, Luma ^a   Ahmad, Hafiz A ^a  

^a Jackson State University   (United States)

Author keywords

HIV; Sub Saharan Africa; Tuberculosis; United States

Indexed keywords

ARTICLE; CAMEROON; CONTROLLED STUDY; GEOGRAPHIC DISTRIBUTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; INFECTION RISK; MIXED INFECTION; MORTALITY; NIGERIA; PANDEMIC; PREVALENCE; RISK FACTOR; SOUTH AFRICA; TREND STUDY; TUBERCULOSIS; UNITED STATES;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 79959825611     PISSN: None     EISSN: 16604601     Source Type: Journal    
DOI: 10.3390/ijerph8062524     Document Type: Article

References (32)

1. Russell, D.G.; Barry, C.E., III; Flynn, J.L. Tuberculosis: What we don't know can, and does, hurt us. Science 2010, 328, 852-856.
2. Lange, C.; Mori, T. Advances in the diagnosis of tuberculosis. Respirology 2010, 15, 220-240.
3. Jasmer, R.M.; Nahid, P.; Hopewell, P.C. Clinical practice. Latent tuberculosis infection. N. Engl. J. Med. 2002, 347, 1860-1866.
4. Kochi, A. Tuberculosis: Distribution, risk factors, mortality. Immunobiology 1994, 191, 325-336.
5. Pluta, K.; Kacprzak, M.M. Use of HIV as a gene transfer vector. Acta Biochim. Pol. 2009, 56, 531-595.
6. Kilmarx, P.H. Global epidemiology of HIV. Curr. Opin. HIV AIDS 2009, 4, 240-246.
7. Klimas, N.; Koneru, A.O.; Fletcher, M.A. Overview of HIV. Psychosom. Med. 2008, 70, 523-530.
8. Carvalho, A.C.; Migliori, G.B.; Cirillo, D.M. Tuberculosis in Europe: A problem of drug resistance or much more? Expert Rev. Respir. Med. 2010, 4, 189-200.
9. Dembele, M.; Saleri, N.; Carvalho, A.C.; Saouadogo, T.; Hien, A.D.; Zabsonre, I.; Koala, S.T.; Simpore, J.; Matteelli, A. Incidence of tuberculosis after HAART initiation in a cohort of HIV-positive patients in Burkina Faso. Int. J. Tuberc. Lung Dis. 2010, 14, 318-323.
10. Seung, K.J.; Omatayo, D.B.; Keshavjee, S.; Furin, J.J.; Farmer, P.E.; Satti, H. Early outcomes of MDR-TB treatment in a high HIV-prevalence setting in Southern Africa. PLoS One 2009, 4, e7186.
11. Schneider, E.; Castro, K.G. Tuberculosis trends in the United States, 1992-2001. Tuberculosis (Edinb.) 2003, 83, 21-29.
12. Fassin, D.; Schneider, H. The politics of AIDS in South Africa: Beyond the controversies. BMJ 2003, 326, 495-497.
13. Habib, A.G. A clinical and epidemiologic update on the interaction between tuberculosis and human immunodeficiency virus infection in adults. Ann. Afr. Med. 2009, 8, 147-155.
14. Small, P.M. Tuberculosis: A new vision for the 21st century. Kekkaku 2009, 84, 721-726.
15. Assam-Assam, J.P.; Penlap, V.B.; Cho-Ngwa, F.; Tedom, J.C.; Ane-Anyangwe, I.; Titanji, V.P. Mycobacterium tuberculosis complex drug resistance pattern and identification of species causing tuberculosis in the West and Centre regions of Cameroon. BMC Infect. Dis. 2011, 11, 94.
16. LoBue, P.A.; Enarson, D.A.; Thoen, T.C. Tuberculosis in humans and its epidemiology, diagnosis and treatment in the United States. Int. J. Tuberc. Lung Dis. 2010, 14, 1226-1232.
17. Moore, R.D. Epidemiology of HIV infection in the United States: Implications for linkage to care. Clin. Infect. Dis. 2011, 52, S208-S213.
18. UNAIDS. Report on the Global AIDS Epidemic, 2006. Available online: http://www.unaids.org/en/KnowledgeCentre/HIVData/GlobalReport/2006/default.asp (accessed on 1 July 2010).
19. WHO. 2007 Tuberculosis facts WHO, 2007. Available online: http://www.who.int/tb/publications/2007/factsheet_2007.pdf (accessed on 1 July 2010).
20. UNAIDS. Frequently Asked Questions about Tuberculosis and HIV, 2006. Available online: http://data.unaids.org/pub/factsheet/2006/tb_hiv_qa.pdf (accessed on 1 July 2010).
21. AVERT. HIV & AIDS in South Africa, 2010. Available online: www.avert.org/aidssouthafrica.htm (accessed on 1 July 2010).
22. Fassin, D. The embodiment of inequality. AIDS as a social condition and the historical experience in South Africa. EMBO Rep. 2003, 4, S4-S9.
23. Mbanya, D.; Ateudjieu, J.; Tagny, C.T.; Moudourou, S.; Lobe, M.M.; Kaptue, L. Risk factors for transmission of HIV in a hospital environment of Yaounde, Cameroon. Int. J. Environ. Res. Public Health 2010, 7, 2085-2100.
24. Reid, S.R. Injection drug use, unsafe medical injections, and HIV in Africa: A systematic review. Harm Reduct. J. 2009, 6, 24.
25. Aliyu, M.H.; Varkey, P.; Salihu, H.M.; Iliyasu, Z.; Abubakar, I.S. The HIV/AIDS epidemic in Nigeria: Progress, problems and prospects. Afr. J. Med. Med. Sci. 2010, 39, 233-239.
26. Powell, R.; Barengolts, D.; Mayr, L.; Nyambi, P. The Evolution of HIV-1 Diversity in Rural Cameroon and its Implications in Vaccine Design and Trials. Viruses 2010, 2, 639-654.
27. Kehinde, A.O.; Obaseki, F.A.; Ishola, O.C.; Ibrahim, K.D. Multidrug resistance to Mycobacterium tuberculosis in a tertiary hospital. J. Natl. Med. Assoc. 2007, 99, 1185-1189.
28. Dau, B.; Holodniy, M. The relationship between HIV infection and cardiovascular disease. Curr. Cardiol. Rev. 2008, 4, 203-218.
29. Boyer, S.; Eboko, F.; Camara, M.; Abe, C.; Nguini, M.E.; Koulla-Shiro, S.; Moatti, J.P. Scaling up access to antiretroviral treatment for HIV infection: The impact of decentralization of healthcare delivery in Cameroon. AIDS 2010, 24, S5-S15.
30. Mbanya, D.; Sama, M.; Tchounwou, P. Current status of HIV/AIDS in Cameroon: How effective are control strategies? Int. J. Environ. Res. Public Health 2008, 5, 378-383.
31. Arcand, J.L.; Wouabe, E.D. Teacher training and HIV/AIDS prevention in West Africa: Regression discontinuity design evidence from the Cameroon. Health Econ. 2010, 19, 36-54.
32. Tchendjou, P.; Same-Ekobo, C.; Nga, A. Tejiokem, M.; Kfutwah, A.; Nlend, A.N.; Tsague, L.; Bissek, A.C.; Ekoa, D.; Orne-Gliemann, J.; Rousset, D.; Pouillot, R.; Dabis, F. Effectiveness of multidrug antiretroviral regimens to prevent mother-to-child transmission of HIV-1 in routine public health services in Cameroon. PLoS One 2010, 5, e10411.